Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: Clinical efficacy, effects on plasma IL-8, and expression of toll-like receptor 2 on granulocytes

Digestive Diseases and Sciences

Volumn 52, Issue 6, 2007, Pages 1427-1433

  Aoki, Hiroshi ^a   Nakamura, Kentaro ^a   Yoshimatsu, Yasushi ^a   Tsuda, Yukiko ^a   Irie, Masaki ^a   Fukuda, Katsuyuki ^a   Hosoe, Nobuo ^a   Takada, Nobuo ^a   Shirai, Koji ^a   Suzuki, Yasuo ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

IL 1 ; Interleukin (IL) 8; Selective granulocyte and monocyte adsorptive apheresis; Toll like receptor 2; Ulcerative colitis

Indexed keywords

BETAMETHASONE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TOLL LIKE RECEPTOR 2;

ADOLESCENT; ADULT; APHERESIS; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; REMISSION; THROMBOCYTE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CYTOKINES; FEMALE; GRANULOCYTES; HUMANS; INTERLEUKIN-8; LEUKAPHERESIS; LEUKOCYTES; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 2;

EID: 34248636240     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9406-8     Document Type: Article

References (37)

1. Shimoyama T, Sawada K, Hiwatashi N (2001) Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 16:1-9
2. Saniabadi AR, Hanai H, Lofberg R (2003) Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7:48-59
3. Hanai H, Watanabe F, Takeuchi K, et al. (2003) Leukcocyte adsorptive apheresis for the treatment of active ulcerative colitis:a prospective uncontrolled pilot study. Clin Gastroenterol Hepatol 1:28-35
4. Kashiwagi N, Sugimura K, Koiwai H, Saniabadi A (2002) Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig. Dis Sci 6:1334-1341
5. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y (2004) Selective granulocytes and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis:a prospective uncontrolled study. Dig Dis Sci 49:565-571
6. Saniabadi AR, Hanai H, Suzuki Y, Bjarnason I, Lofberg R (2005) Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system:an adjunct or an alternative to drug therapy? J Clin Apher 20:171-184
7. Kanke K, Nakano M, Hiraishi H (2004) Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liv Dis 36:512-518
8. Naganuma M, Funakoshi S, Sakuraba A, Hibi T (2004) Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 10:251-257
9. Yamamoto T, Umegae S, Kitagawa T (2004) Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 20:783-792
10. Domenech E, Hinojosa J, Esteve-Comas M, Gassull A, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU) (2004) Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 20:1347-1352
11. Suzuki Y, Yoshimora N, Saito Y, Saniabadi A (2006) A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci (in press)
12. McCarthy DA, Rampton DS, Liu Y-C (1991) Peripheral blood neutrophils in inflammatory bowel disease:morphological evidence of in vivo activation in active disease. Clin Exp Immunol 86:489-493
13. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H (1994) Increased macrophage subsets in inflammatory bowel disease:apparent recruitment from peripheral blood monocytes. Gut 35:669-674
14. Meuret G, Bitzi A, Hammer B (1978) Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology 74:501-503
15. Brannigan AE, O'Connell PR, Hurley H (2000) Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13:361-366
16. Cassatella MA (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26
17. Nikolaus S, Bauditz J, Gionchetti P (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 42:470-476
18. Mahida YR (2000) The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 6:21-33
19. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12:S3-S9
20. Allison MC, Dhillon AP, Lewis WG, Pounder RE, eds (1998) Inflammatory bowel disease. Mosby, London, pp 15-95
21. Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15-22
22. Limburg P, David M, Ahlquist A, Sandborn WJ (2000) Faecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhoea referred for colonoscopy. Am J Gastroenterol 95:2831-2837
23. Hiraishi K, Takeda Y, Shiobara N, Saniabadi A (2003) Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads:an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 7:334-340
24. D'Arrigo C, Candal-Couto JJ, Greer M (1993) Human neutrophil Fc receptor-mediated adhesion under flow: a hallow fiber model of intravascular arrest. Clin Exp Immunol 100:173-179
25. Pierik M, Joossens S, Van Steen K (2006) Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 12:1-8
26. Rachmilewitz D (on behalf of an international study group) (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82-86
27. Kurt-Jones EA, Whitney MC, Padgett A, Gosselin K, Newburger PE, Finberg RW (2002) Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860-1868
28. Swaak AJ, van den Brink HG, Aarden LA (1997) Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis. Ann Rheum Dis 56:693-695
29. Lerebours E, Bussel A, Modigliani R, Bastit D, Florent C, Rabian C (1994) Treatment of Crohn's disease by lymphocyte apheresis:a randomized controlled trial. Gastroenterology 107:357-361
30. Isaacs KL, Lewis JD, Sandborn WJ, Sands BE, Targan SR (2005) State of the art:IBD therapy and clinical trials in IBD. Inflamm Bowel Dis 11:S3-S12
31. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131-1139
32. Kanai K, Watanabe M (2005) Clinical application of human CD4+CD25+ regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opin Biol Ther 5:451-462
33. King C, Ilic A, Koelsch K, Sarvetnick N (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265-277
34. Sleasman JW (1996) The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 10:57-61
35. Banerjee D, Liou HC, Sen R (2005) c-Rel-dependent priming of naive T Cells by inflammatory cytokines. Immunity 23:445-458
36. Hanai H, Watanabe F, Saniabadi A, Matsushita I, Takeuchi K, Iida T (2002) Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349-2353
37. Dionne S, D'Agata ID, Hiscott J, Vanounou T, Seidman EG (1998) Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol 112:435-442